Purple Biotech Ltd.
PPBT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614744
No open-market purchases or sales by Purple Biotech Ltd. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $141.0K in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Purple Biotech Ltd. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- 0 vs. Q1 2024
- Shares held
- 1.91M
- −729.9K (−27.7%) vs. Q1 2024
- Total value
- $775.9K
- −$991.8K (−56.1%) vs. Q1 2024
- New holders
- 3
- 5 more added
- Sold out
- 3
- 3 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PPBT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $141.0K |
| Q1 2026 | 15 | $305.6K |
| Q4 2025 | 19 | $513.2K |
| Q3 2025 | 16 | $75.9K |
| Q2 2025 | 14 | $133.7K |
| Q1 2025 | 9 | $134.3K |
| Q4 2024 | 14 | $377.9K |
| Q3 2024 | 11 | $946.1K |
| Q2 2024 | 21 | $775.9K |
| Q1 2024 | 21 | $1.77M |
| Q4 2023 | 20 | $1.90M |
| Q3 2023 | 18 | $275.9K |
| Q2 2023 | 17 | $388.3K |
| Q1 2023 | 16 | $224.2K |
| Q4 2022 | 15 | $238.6K |
| Q3 2022 | 11 | $224.0K |
| Q2 2022 | 14 | $310.2K |
| Q1 2022 | 14 | $1.77M |
| Q4 2021 | 13 | $4.09M |
| Q3 2021 | 12 | $5.27M |
| Q2 2021 | 13 | $3.72M |
| Q1 2021 | 15 | $2.40M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Purple Biotech Ltd.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,358,000 | $552.7K | 0.01% | −757,000−35.8% | Reduced |
| Kingswood Wealth Advisors, LLC | 208,060 | $84.7K | 0.01% | +21,960+11.8% | Added |
| Morgan Stanley | 203,000 | $82.6K | 0.00% | +66,390+48.6% | Added |
| Citadel Advisors LLC | 24,628 | $10.2K | 0.00% | −33,395−57.6% | Reduced |
| Venture Visionary Partners LLC | 22,161 | $9.02K | 0.00% | +6,608+42.5% | Added |
| Virtu Financial LLC | 19,273 | $8.00K | 0.00% | +3,195+19.9% | Added |
| Wealth Advisors of Iowa, LLC | 14,270 | $5.81K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 12,666 | $5.26K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 12,852 | $5.23K | 0.00% | +1,241+10.7% | Added |
| HRT Financial LP | 13,739 | $5.00K | 0.00% | +13,739 | New |
| Raymond James & Associates | 10,000 | $4.07K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 4,000 | $1.44K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,158 | $1.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 859 | $356 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 400 | $166 | 0.00% | −2,806−87.5% | Reduced |
| Global Retirement Partners, LLC | 336 | $137 | 0.00% | 00.0% | Unchanged |
| North Star Investment Management Corp. | 300 | $122 | 0.00% | 00.0% | Unchanged |
| Sound Income Strategies, LLC | 100 | $41 | 0.00% | 00.0% | Unchanged |
| Aviso Financial Inc. | 51 | $20 | 0.00% | +51 | New |
| Rhumbline Advisers | 16 | $6 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 708 | $0 | 0.00% | +708 | New |
| XTX Topco Ltd | 0 | $0 | 0.00% | −29,099−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −21,438−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −5−100.0% | Sold out |